Skip to content

Prospective, multi-center, trial of mechanical thrombectomy for acute ischemic stroke using Versi Retriever

Prospective, multi-center, trial of mechanical thrombectomy for acute ischemic stroke using Versi Retriever - Prospective trial of Versi Thrombectomy (VERTH)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035632
Enrollment
60
Registered
2019-01-24
Start date
2019-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ischemic stroke

Interventions

mechanical thrombectomy using Versi Retriever

Sponsors

Kobe City Medical Center General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 acute onset neurological symptom related to occluded vessel 2 within 8 hours from onset to treatment or within 24 hours from onset to treatment with imaging diagnosis 3 contra-indication or failed to intravenous rt-PA 4 accessible occlusion at ICA, MCA, VA, BA, PCA 5 5-30 of NIHSS 6 0-2 of mRS before onset 7 obtain documented informed content

Exclusion criteria

Exclusion criteria: 1 following condition; arterial dissection, engird, inaccessible turtuousity, difficult access by 50% or more stenosis, acute intracranial hemorrhage, space occping lesion or brain tumor, major early ischemic change in brain 2 occlude 2 major vessel territory 3 allege for contrast media, 4 abnormal PTT/APTT within 4 hours intravenous heparin 5 hemorrhagic tendency or 3 or more INR with Warfarin administration 6 30000cc or less of Platelet 7 50mg/dL or less of blood sugar 8 uncontrolled blood pressure, 185mmHg or more at systolic, 110mmHg or more at diastolic 9 90days or less life expancy 10 pregnant or lactating 11 join another trial of medicine or medical device 12 ineligible for trail

Design outcomes

Primary

MeasureTime frame
Good clinical outcome (modified Rankin score 0-2) and death 90days after procedure

Secondary

MeasureTime frame
1 successful recanalization after 3 passes of device 2 successful recanalization after procedure 3 new territory emolization related to procedure 4 symptomatic and asymtomatic intracranial hemorrhage 24 hours after procedure 5 symptomatic intracranial hemorrhage 24 hours after procedure 6 good clinical outcome (mRS 0-2 or 10 or more improvement of NIHSS) 90 days after procedure 7 severe adverse event related to device and procedure 90 days after procedure 8 mRS and NIHSS 90days after onset

Countries

Japan

Contacts

Public ContactNobuyuki Sakai

Kobe City Medical Center General Hospital Neurosurgery

n.sakai@siren.ocn.ne.jp078-302-4321

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026